Literature DB >> 3753515

Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone.

P Kalix, R A Glennon.   

Abstract

The alkaloid (-)cathinone is a potent stimulant with pharmacological properties closely resembling those of (+)amphetamine. Since (-)cathinone is capable of inducing release at physiological catecholamine storage sites, it has been suggested that (-)cathinone and (+)amphetamine have the same mechanism of action. In the present study, the potency of (-)cathinone in inducing the release of radioactivity from 3H-dopamine prelabelled tissue of the rat caudate nucleus was compared to that of several structural analogs, i.e. to that of four other aminophenones. (-)Cathinone was found to be the most potent of the compounds under investigation, and among these only demethylcathinone had an effect that was within the same order of magnitude as that of (-)cathinone. Furthermore, (-)cathinone and two of its analogs were evaluated in behavioral experiments with regard to their ability to substitute for (+)amphetamine in rats trained to discriminate between (+)amphetamine and saline. It was found that, unlike the other aminophenones, (-)cathinone is capable of producing (+)amphetamine-like stimulus effects, and these can be antagonized by haloperidol in a dose-related manner. Taken together, these findings support the hypothesis that (+)amphetamine and (-)cathinone produce their central stimulant effect via the same dopaminergic mechanism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753515     DOI: 10.1016/0006-2952(86)90380-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  16 in total

Review 1.  Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.

Authors:  Louis J De Felice; Richard A Glennon; Sidney S Negus
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

2.  Catha edulis, a plant that has amphetamine effects.

Authors:  P Kalix
Journal:  Pharm World Sci       Date:  1996-04

Review 3.  Baths salts, spice, and related designer drugs: the science behind the headlines.

Authors:  Michael H Baumann; Ernesto Solis; Lucas R Watterson; Julie A Marusich; William E Fantegrossi; Jenny L Wiley
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 4.  Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

Authors:  Michael H Baumann; Mohammad O Bukhari; Kurt R Lehner; Sebastien Anizan; Kenner C Rice; Marta Concheiro; Marilyn A Huestis
Journal:  Curr Top Behav Neurosci       Date:  2017

5.  "Deconstruction" of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter.

Authors:  Renata Kolanos; Ernesto Solis; Farhana Sakloth; Louis J De Felice; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2013-10-31       Impact factor: 4.418

Review 6.  Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances.

Authors:  Tyler W E Steele; Jose M Eltit
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

7.  Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Dina M Francescutti; Katherine E Sykes; Mrudang M Shah; Abiy M Mohammed; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2012-02-09       Impact factor: 5.372

Review 8.  Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.

Authors:  Richard A Glennon
Journal:  Adv Pharmacol       Date:  2014

9.  Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.

Authors:  Krasnodara Cameron; Renata Kolanos; Rakesh Vekariya; Rakesh Verkariya; Louis De Felice; Richard A Glennon
Journal:  Psychopharmacology (Berl)       Date:  2013-01-31       Impact factor: 4.530

10.  Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Dina M Francescutti; Catherine E Sykes; Mrudang M Shah; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2013-01-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.